Angiogenesis and Hepatic Fibrosis： Western and Chinese Medicine Therapies on the Road 被引量：7

Angiogenesis and Hepatic Fibrosis: Western and Chinese Medicine Therapies on the Road

导出

摘要 Hepatic fibrosis is a common feature of almost all chronic liver diseases. Formation of new vessels （angiogenesis） is a process strictly related to the progressive fibrogenesis which leads to cirrhosis and liver cancer. This review mainly concerns the relationship between angiogenesis and hepatic fibrosis, by considering the mechanism of angiogenesis, cells in angiogenesis, anti-angiogenic and Chinese medicine therapies. Hepatic fibrosis is a common feature of almost all chronic liver diseases. Formation of new vessels （angiogenesis） is a process strictly related to the progressive fibrogenesis which leads to cirrhosis and liver cancer. This review mainly concerns the relationship between angiogenesis and hepatic fibrosis, by considering the mechanism of angiogenesis, cells in angiogenesis, anti-angiogenic and Chinese medicine therapies.

作者 WANG Jing-si ZHANG Qiu-yun CHENG Jin-lian CHEN Lan-yu YAO Nai-li SUN Gui-zhi CHU Yu-ling

机构地区 Department of Hepatology College of Traditional Chinese Medicine Affiliated to Capital Medical University Department of Good Clinical Practice Department of Hepatology Department of Gastroenterology Department of Oncology

出处《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2018年第9期713-720,共8页 中国结合医学杂志（英文版）

基金 Supported by National Natural Science Foundation Project(No.81573767) Doctoral Innovation Fund from Chin Academy of Chinese Medical Sciences(No.CX201404)

关键词 ANGIOGENESIS hepatic fibrosis REVIEW Chinese medicine angiogenesis hepatic fibrosis review Chinese medicine

分类号 R575.2 [医药卫生—消化系统]

引文网络
相关文献

参考文献4

1Xue-Ke Zhao,Ming-Liang Cheng,Rong-Min Wu,Yu-Mei Yao,Mao Mu,Juan-Juan Zhu,Bao-Fang Zhang,Ming-Yu Zhou.Effect of Danshao Huaxian capsule on Gremlin and bone morphogenetic protein-7 expression in hepatic fibrosis in rats[J].World Journal of Gastroenterology,2014,20(40):14875-14883. 被引量：11
2Wen-Ce Zhou,Quan-Bao Zhang,Liang Qiao.Pathogenesis of liver cirrhosis[J].World Journal of Gastroenterology,2014,20(23):7312-7324. 被引量：82
3Xiao-Lu Liang,Jia-Ying Yuan.Effect of Chinese herbal compound on liver fibrosis in rabbits with schistosomiasis by B-ultrasound[J].Asian Pacific Journal of Tropical Medicine,2013,6(8):658-662. 被引量：2
4Claudia Paternostro,Ezio David,Erica Novo,Maurizio Parola.Hypoxia,angiogenesis and liver fibrogenesis in the progression of chronic liver diseases[J].World Journal of Gastroenterology,2010,16(3):281-288. 被引量：23

二级参考文献41

1Xiao-Hui Si Lian-Jun Yang Research Institute of Stomatology,the Ninth People’s Hospital,Shanghai Second Medical University,Shanghai 200011,ChinaDepartment of Pathology,Fourth Military Medical University,Xi’an 710033,Shaanxi Province,China.Extraction and purification of TGFβ and its effect on the induction of apoptosis of hepatocytes[J].World Journal of Gastroenterology,2001,7(4):527-531. 被引量：15
2Giovanni Tarantino,Silvia Savastano,Annamaria Colao.Hepatic steatosis,low-grade chronic inflammation and hormone/growth factor/adipokine imbalance[J].World Journal of Gastroenterology,2010,16(38):4773-4783. 被引量：24
3Xiao-Xia Geng, Qin Yang, Ru-Jia Xie, Xin-Hua Luo, Cheng-Xiu Li and Ming-Liang Cheng Guizhou, China Department of Infectious Diseases, Affiliated Hospital of Guiyang Medical College ,Department of Pathophysiology, Guiyang Medical College ,Depart- ment of Infectious Diseases, People’ s Hospital of Guizhou Province ,and Department of Pharmacology, Guiyang Medical College.Effects of Dan-Shao-Hua-Xian on the expression of collagen type I and III in rats with hepatic fibrosis[J].Hepatobiliary & Pancreatic Diseases International,2004,3(4):558-563. 被引量：4
4Hong-Zhu Lu,Jian-Hua Zhou.Hepatitis B virus X protein up-regulates tumor necrosis factor-α expression in cultured mesangial cells via ERKs and NF-κB pathways[J].Asian Pacific Journal of Tropical Biomedicine,2013,3(3):217-222. 被引量：16
5Sheik Abdulazeez Sheriff,Thiruvengadam Devaki.Lycopene stabilizes lipoprotein levels during D-galactosamine/lipopolysaccharide induced hepatitis in experimental rats[J].Asian Pacific Journal of Tropical Biomedicine,2012,2(12):975-980. 被引量：4
6Ya-Ling Lin,Rakesh Ramanujum,Shiping He.Infection of Schistosomiasis japanicum is likely to enhance proliferation and migration of human breast cancer cells:mechanism of action of differential expression of MMP2 and MMP9[J].Asian Pacific Journal of Tropical Biomedicine,2011,1(1):23-28. 被引量：9
7Bo-Lin Chen,Jie Peng,Qing-Fu Li,Min Yang,Yuan Wang,Wei Chen.Exogenous bone morphogenetic protein-7 reduces hepatic fibrosis inSchistosoma japonicum-infected micevia transforming growth factor-β/Smad signaling[J].World Journal of Gastroenterology,2013,19(9):1405-1415. 被引量：21
8Guo-Cai Lv,Jin-Mei Yao,Yi-Da Yang,Lin Zheng,Ji-Fang Sheng,Yu Chen,Lan-Juan Li.Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis[J].World Journal of Gastroenterology,2013,19(22):3481-3486. 被引量：13
9Xiao-XiaGeng,QinYang,Ru-JiaXie,Xin-HuaLuo,BingHan,LiMa,Cheng-XiuLi,Ming-LiangCheng.In vivo effects of Chinese herbal recipe, Danshaohuaxian, on apoptosis and proliferation of hepatic stellate cells in hepatic fibrotic rats[J].World Journal of Gastroenterology,2005,11(4):561-566. 被引量：8
10Qin Yang,Ru-Jia Xie,Xiao-Xia Geng,Xin-Hua Luo,Bing Han,Ming-Liang Cheng.Effect of Danshao Huaxian capsule on expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in fibrotic liver of rats[J].World Journal of Gastroenterology,2005,11(32):4953-4956. 被引量：16

共引文献114

1牛淑利,刘雨,郭永泽,闫华楠,刘献波.肠道菌群失调与肝硬化及并发症关系的研究进展[J].世界最新医学信息文摘,2020(94):79-81.
2Wen-Jun Shen,Gong Chen,Min Wang,Shan Zheng.Liver fibrosis in biliary atresia[J].World Journal of Pediatrics,2019,15(2):117-123. 被引量：22
3高俊茶,高丽君,吕晓萍.血管增生与肝纤维化研究进展[J].中国老年学杂志,2015,35(2):552-555. 被引量：2
4李发武,卢放根,吴福全,王文琦.靶向性血小板衍生生长因子siRNA对肝星状细胞增殖的影响[J].临床和实验医学杂志,2010,9(9):643-645.
5徐珊珊,赵金满,杨思贤.门脉高压肝脏小叶间动脉与小叶间静脉血管内皮生长因子受体的分布[J].世界华人消化杂志,2010,18(17):1756-1760. 被引量：9
6王照红,王志明.肝细胞癌缺氧微环境下PHD2的表达及其与血管生成的关系[J].中国普通外科杂志,2010,19(10):1113-1117. 被引量：5
7都金星,刘平,孙明瑜,陶庆,章李军,陈高峰,胡义扬,刘成海,徐列明.下瘀血汤对四氯化碳诱导的肝硬化大鼠肝脏血管新生的抑制作用[J].中西医结合学报,2011,9(8):878-887. 被引量：14
8张俊杰.中医药在抗肝纤维化过程中对病理性血管新生干预作用的研究进展[J].中国当代医药,2013,20(11):22-24. 被引量：4
9缪青,陈世耀.血管生成在肝硬化门脉高压(PHT)中的研究进展[J].复旦学报（医学版）,2013,40(4):495-497. 被引量：2
10ZHANG Yi,MA Li-tian,LI Jie,QIAO Yu,LIU Jun-ye,WANG Jin,REN Qin-you,HU Jin-tao,ZHENG Jin.Anti-fibrotic Effects and Mechanism of Shengmai Injection(生脉注射液)on Human Hepatic Stellate Cells LX-2[J].Chinese Journal of Integrative Medicine,2019,25(3):197-202. 被引量：5

同被引文献36

1易善华,李永福.黄芪注射液合丹参注射液治疗慢性肝炎肝硬化45例[J].浙江中医杂志,2007,42(4):243-243. 被引量：10
2严诗楷,赵静,窦圣姗,姜鹏,柳润辉,张卫东.基于系统生物学与网络生物学的现代中药复方研究体系[J].中国天然药物,2009,7(4):249-259. 被引量：52
3舒建昌,陈莲香,邓亮,吕霞,何雅军,朱海燕,付景,叶国荣,周海华.护肝解纤汤治疗肝纤维化及其作用机制的初步研究[J].中华肝脏病杂志,2010,18(3):189-193. 被引量：9
4王仲霞,王立福,王葽,杨慧银,周双男,白云峰,朱云,侯宝国,李永纲.益气破血行气通络中药对乙型肝炎代偿期肝硬化患者的治疗作用[J].中西医结合肝病杂志,2012,22(1):5-7. 被引量：27
5唐露露,刘丹青,李睿,董婷,陈永华,江海林,杨文明.肝豆扶木汤对TX小鼠肝纤维化的保护作用及机制研究[J].中国中西医结合杂志,2018,38(12):1461-1466. 被引量：19
6陈佳良,杨雪,张群,孙乐,刘遥,朱冰冰,王宪波.熊去氧胆酸联合中药治疗对原发性胆汁性胆管炎患者生物化学应答的影响:一项基于真实世界的队列研究[J].中华肝脏病杂志,2018,26(12):909-915. 被引量：28
7Hong-feng Zhang,Yan-li Wang,Cheng Gao,Yan-ting Gu,Jian Huang,Jin-hui Wang,Jia-hong Wang,Zhou Zhang.Salvianolic acid A attenuates kidney injury and inflammation by inhibiting NF-κB and p38 MAPK signaling pathways in 5/6 nephrectomized rats[J].Acta Pharmacologica Sinica,2018,39(12):1855-1864. 被引量：22
8杨文明,方芳,汪美霞,汪瀚,董婷.肝豆扶木汤治疗Wilson病肝纤维化的临床研究[J].中医药临床杂志,2014,26(11):1111-1113. 被引量：23
9李甲,徐凌忠.川穹嗪注射液对小鼠急性酒精性肝损伤的保护作用观察[J].淮海医药,2015,33(3):250-252. 被引量：5
10朱春雾,吕靖,赵志敏,陶艳艳,刘成海.五味子酯甲抑制肝窦内皮细胞功能及血管新生的活性评价[J].中国中药杂志,2016,41(2):279-284. 被引量：12

引证文献7

1田晓玲,唐陈琴,张彧,陈斌.基于细胞自噬探讨中医药防治肝纤维化的作用机制研究[J].世界科学技术-中医药现代化,2023,25(11):3692-3703.
2涂海斌,林健玲,林恢,张菊珍.抗纤一号治疗乙肝肝纤维化效果的初步研究[J].当代医学,2020,26(1):29-32. 被引量：2
3高俪原,梁宝瑜,金春,李余佳,王桭屹,张峰,郑仕中.血管新生在肝脏疾病发生与发展中作用的研究进展[J].生理科学进展,2020,51(3):193-197. 被引量：8
4无.Traditional Chinese Medicine nursing protocols for liver cirrhosis[J].中西医结合护理（中英文）,2020,6(5):289-296.
5于中飞,刘鲁英.白藜芦醇对链脲佐菌素诱导糖尿病小鼠肾脏损伤的保护作用[J].糖尿病新世界,2021,24(2):22-27. 被引量：3
6魏涛华,杨文明,唐露露,郝文杰,陈永华,张荣信,董薇,江海林,杨悦,杨玉龙.基于网络药理学探讨肝豆扶木汤治疗肝豆状核变性肝纤维化的作用机制及实验验证[J].中国中西医结合杂志,2021,41(8):981-990. 被引量：17
7夏睿琦,曾晓清,简佑容,陈世耀,高虹.血管生成在肝硬化门脉高压中的作用及中医药治疗进展[J].中西医结合肝病杂志,2024,34(5):465-468.

二级引证文献30

1王欣,安梓铭,董慧琳,聂红明.补肾柔肝方抑制血管新生的抗小鼠肝纤维化作用机制[J].上海中医药大学学报,2022,36(S01):167-173. 被引量：1
2宁佐伟,李秀梅,王亚东,李洋.Alamandine对肝纤维化大鼠肝窦血管生成的抑制作用[J].现代消化及介入诊疗,2020,25(12):1566-1570. 被引量：1
3罗茂权,黄菊芳,黎敏航,李炜,罗婷,罗伟生.中药治疗肝纤维化的用药规律研究[J].广西医学,2021,43(1):52-55. 被引量：3
4鲁有水.乙肝抗纤汤联合恩替卡韦治疗乙型肝炎肝硬化的效果分析[J].当代医药论丛,2021,19(10):179-180.
5郝文杰,杨文明,魏涛华,董薇,李祥,江海林,杨悦,钱南南.基于“肝络微癥积”学说探讨中医药抗肝豆状核变性肝纤维化治疗策略[J].北京中医药大学学报,2022,45(3):307-312. 被引量：11
6胡光,李丹,陈阳,张云罗,肖袁媛,杨世洲,周倩.二乙基亚硝胺诱导斑马鱼肝癌模型的探索与优化[J].重庆理工大学学报（自然科学）,2022,36(4):262-267. 被引量：1
7杨悦,杨文明,魏涛华,唐露露,郝文杰,钱南南,饶志红,杨玉龙.肝豆扶木汤通过JNK信号通路对Wilson病肝纤维化小鼠的干预作用[J].中国实验方剂学杂志,2022,28(12):119-126. 被引量：10
8唐露露,杨文明,董婷,张静,陈怀珍,汪瀚,魏涛华,江海林,杨悦.肝豆扶木颗粒治疗肝肾亏虚兼痰瘀互结型Wilson病患者的临床疗效[J].中国实验方剂学杂志,2022,28(12):127-132. 被引量：13
9张亚,吕文良.基于CiteSpace中医药治疗肝纤维化的可视化分析[J].中国医药导报,2022,19(19):129-132. 被引量：4
10魏涛华,钱南南,杨文明,谢道俊,鲍远程,童建兵,郝文杰,杨悦.基于肝脏硬度值联合多维指标探讨不同中医证型Wilson病肝纤维化的临床特征[J].中西医结合心脑血管病杂志,2022,20(15):2738-2742. 被引量：5

1Ni Shen,Rui Zhang,Hao-Rui Zhang,Hao-Yang Luo,Wei Shen,Xin Gao,Da-Zhi Guo,Jie Shen.Inhibition of retinal angiogenesis by gold nanoparticles via inducing autophagy[J].International Journal of Ophthalmology(English edition),2018,11(8):1269-1276. 被引量：2
2王学文.七选五阅读专项训练[J].教学考试,2017,0(30):62-63.
3Tian-yi YUAN,Di CHEN,Lian-hua FANG,Guan-hua DU.Curcumin,from health product to medicine[J].中国药理学与毒理学杂志,2018,32(4):328-328.
4Confidence Is Built,Not Inborn[J].英语角,2018(7):38-39.
5Cancer Biology & Medicine首个影响因子4.607[J].中国肿瘤临床,2018,45(15):784-784.
6Lei YANG,Nuan LIU,Wei ZHAO,Xing LI,Qian WANG,Li HAN,Wen-jing QI,Yan-ke WANG,Bing-yu MAO.Angiogenesis function of astragaloside Ⅳ in rats with myocardial infarction via PKD1-HDAC5-VEGF pathway[J].中国药理学与毒理学杂志,2018,32(4):323-324. 被引量：1
7Ting ZENG,Zhen-zhen WANG,Nai-hong CHEN.The mTORC1 signaling network underlying the pathogenesis and treatment of depression: new insights into rapid-acting antidepressant therapies[J].中国药理学与毒理学杂志,2018,32(4):331-331. 被引量：1
8付景云,关雅心,黄世英,孙芳,黄圣婷,徐兆.以问题为中心结合标准化临床路径实习带教法对MBBS留学生的教学[J].昆明医科大学学报,2018,39(7):137-140. 被引量：18
9张俊俊,王焱,杜趁香,晋熙梦.脑特异性血管抑制因子-1在宫颈鳞癌中的表达及其与人乳头瘤病毒感染的关系[J].首都医科大学学报,2018,39(4):569-574. 被引量：4
10袁丽君,段云友,赵联璧.下肢静脉超声检查:美国超声医学会外周静脉超声检查指南解读[J].中华医学超声杂志（电子版）,2018,15(4):243-245. 被引量：4

Chinese Journal of Integrative Medicine

2018年第9期

浏览历史

内容加载中请稍等...